Most Recent Articles about ABT
Abbott (ABT) Upgraded to Buy: What Does It Mean for the Stock? http://www.zacks.com/stock/news/412541/abbott-abt-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-412541 May 10, 2019 - Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Stock Reports for Verizon, Abbott & Illinois Tool Works http://www.zacks.com/research-daily/411019/top-stock-reports-for-verizon-abbott-illinois-tool-works?cid=CS-ZC-FT-411019 May 08, 2019 - Top Stock Reports for Verizon, Abbott & Illinois Tool Works
Bruker (BRKR) Q1 Earnings Beat Estimates, Guidance Upbeat http://www.zacks.com/stock/news/411255/bruker-brkr-q1-earnings-beat-estimates-guidance-upbeat?cid=CS-ZC-FT-411255 May 08, 2019 - Bruker's (BRKR) current focus on product development through higher R&D investment stokes investors' positive sentiment around the stock.

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals